


Regeneron Disclaims an Aflibercept Formulation Patent in Response to Celltrion PGR

Humira’s End of Reign

China’s Hatch-Waxman Act: Patent Linkage System Implemented in the 4th Amendment to the Chinese Patent Law

Does the Term “Human Antibody” Include Humanized Antibodies?
